TASK FORCES:

The Gold Standard is a workplace- based program that focuses on lowering the risk of cancer.
Visit Website

The Life Sciences Consortium (LSC) brings together oncology companies to accelerate discovery and development of new therapies for all cancer patients. Visit Website

Leadership Team

Executive Committee of the CEO Roundtable on Cancer

Christopher A. Viehbacher

Chairman, CEO Roundtable on Cancer
Chief Executive Officer, Sanofi

William C. Weldon

Immediate Past Chairman, CEO Roundtable on Cancer
Chairman of the Board, Johnson & Johnson

Robert A. Ingram

Past Chairman and Co-Founder, CEO Roundtable on Cancer
General Partner, Hatteras Venture Partners

Martin J. Murphy, Ph.D., DMedSc

Chief Executive Officer, CEO Roundtable on Cancer
Chairman of the Board and Chief Executive Officer, AlphaMed Consulting

Life Sciences Consortium Task Force Leadership

Gregory A. Curt, M.D.

Co-Chairman, Life Sciences Consortium Task Force
US Medical Science Lead for Emerging Products, AstraZeneca Oncology

Mace Rothenberg, M.D.

Co-Chairman, Life Sciences Consortium Task Force
Senior Vice President of Clinical Development and Medical Affairs for the Oncology Business Unit at Pfizer’s Global Research and Development

CEO Cancer Gold StandardTM Task Force Leadership

Judy O'Hagan

Co-Chair, CEO Cancer Gold StandardTM
Vice President, US, Human Resources, Sanofi

CEO Roundtable on Cancer Staff

John N. Dornan

Executive Director, CEO Roundtable on Cancer

CEO Cancer Gold StandardTM Task Force Leadership

Fikry W. Isaac, MD, MPH, FACOEM

Co-Chair, CEO Cancer Gold StandardTM
Vice President of Global Health Services, Johnson & Johnson